Work

Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment

Year: 2020

Type: article

Study design: Observational Study

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.01.026

Authors: Laura J. Havrilesky, Stephanie Lim, Jessie A. Ehrisman, Amelia Lorenzo, Angeles Alvarez Secord, Jui-Chen Yang, F. Reed Johnson, Juan Marcos Gonzalez, Shelby D. Reed

Institutions: Duke University, Duke Medical Center, Duke University Health System, Duke Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca

OpenAlex ID: W3001632091

FWCI: 1.845

Cites: 40

Cited by: 32

Related to: 10